BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 75 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

BLACK DIAMOND THERAPEUTICS I shareholders Q2 2023
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 563,233$2,844,3270.07%
Quantamental Technologies LLC 25,377$128,1540.05%
HERBST GROUP, LLC 13,635$68,8570.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 696,969$3,519,6930.04%
Point72 Asset Management, L.P. 2,000,000$10,100,0000.03%
Verition Fund Management LLC 450,691$2,275,9900.03%
Tekla Capital Management LLC 131,990$666,5500.03%
Ergoteles LLC 100,000$505,0000.02%
Beacon Capital Management, LLC 15,615$78,8560.02%
Candriam S.C.A. 500,009$2,525,0450.02%
Maven Securities LTD 187,513$946,9410.01%
BOOTHBAY FUND MANAGEMENT, LLC 109,293$551,9300.01%
Ausdal Financial Partners, Inc. 15,000$75,7500.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$378,7500.01%
MOORE CAPITAL MANAGEMENT, LP 50,000$252,5000.00%
Renaissance Technologies 220,700$1,1150.00%
Cutler Group LLC / CA 11,100$60.00%
Cubist Systematic Strategies, LLC 23,210$117,2110.00%
JPMORGAN CHASE & CO 1,080,059$5,454,2980.00%
ACADIAN ASSET MANAGEMENT LLC 53,365$2680.00%
External links

This page lists BLACK DIAMOND THERAPEUTICS I's shareholders in Q2 2023. To view BLACK DIAMOND THERAPEUTICS I's shareholder history, click here.